 | • レポートコード：GIR-2104Z00799 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルツハイマー病診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルツハイマー病診断の種類別市場規模（遺伝子検査、神経学的検査、ミニメンタルステート検査（MMSE）、脳画像検査、その他）、用途別市場規模（診療所、病院、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルツハイマー病診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、TauRx、Alector、Accera、Treventis、Neuro-Bio、Cognition Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：遺伝子検査、神経学的検査、ミニメンタルステート検査（MMSE）、脳画像検査、その他 ・用途別分析2016年-2026年：診療所、病院、診断センター、その他 ・アルツハイマー病診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルツハイマー病診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルツハイマー病診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルツハイマー病診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルツハイマー病診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alzheimer’s Disease Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alzheimer’s Disease Diagnostic size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Alzheimer’s Disease Diagnostic market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alzheimer’s Disease Diagnostic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Genetic testing
Neurological exam
Mini-mental state exam (MMSE)
Brain imaging
Other
Market segment by Application, can be divided into
Clinics
Hospitals
Diagnostic Centers
Other
Market segment by players, this report covers
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Diagnostic
1.2 Classification of Alzheimer’s Disease Diagnostic by Type
1.2.1 Overview: Global Alzheimer’s Disease Diagnostic Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type in 2020
1.2.3 Genetic testing
1.2.4 Neurological exam
1.2.5 Mini-mental state exam (MMSE)
1.2.6 Brain imaging
1.2.7 Other
1.3 Global Alzheimer’s Disease Diagnostic Market by Application
1.3.1 Overview: Global Alzheimer’s Disease Diagnostic Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Global Alzheimer’s Disease Diagnostic Market Size & Forecast
1.5 Global Alzheimer’s Disease Diagnostic Market Size and Forecast by Region
1.5.1 Global Alzheimer’s Disease Diagnostic Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Alzheimer’s Disease Diagnostic Market Size by Region, (2016-2021)
1.5.3 North America Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)
1.5.4 Europe Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)
1.5.6 South America Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Alzheimer’s Disease Diagnostic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alzheimer’s Disease Diagnostic Market Drivers
1.6.2 Alzheimer’s Disease Diagnostic Market Restraints
1.6.3 Alzheimer’s Disease Diagnostic Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Alzheimer’s Disease Diagnostic Product and Solutions
2.1.4 Eli Lilly Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 TauRx
2.2.1 TauRx Details
2.2.2 TauRx Major Business
2.2.3 TauRx Alzheimer’s Disease Diagnostic Product and Solutions
2.2.4 TauRx Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 TauRx Recent Developments and Future Plans
2.3 Alector
2.3.1 Alector Details
2.3.2 Alector Major Business
2.3.3 Alector Alzheimer’s Disease Diagnostic Product and Solutions
2.3.4 Alector Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Alector Recent Developments and Future Plans
2.4 Accera
2.4.1 Accera Details
2.4.2 Accera Major Business
2.4.3 Accera Alzheimer’s Disease Diagnostic Product and Solutions
2.4.4 Accera Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Accera Recent Developments and Future Plans
2.5 Treventis
2.5.1 Treventis Details
2.5.2 Treventis Major Business
2.5.3 Treventis Alzheimer’s Disease Diagnostic Product and Solutions
2.5.4 Treventis Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Treventis Recent Developments and Future Plans
2.6 Neuro-Bio
2.6.1 Neuro-Bio Details
2.6.2 Neuro-Bio Major Business
2.6.3 Neuro-Bio Alzheimer’s Disease Diagnostic Product and Solutions
2.6.4 Neuro-Bio Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Neuro-Bio Recent Developments and Future Plans
2.7 Cognition Therapeutics
2.7.1 Cognition Therapeutics Details
2.7.2 Cognition Therapeutics Major Business
2.7.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Product and Solutions
2.7.4 Cognition Therapeutics Alzheimer’s Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cognition Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Alzheimer’s Disease Diagnostic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Alzheimer’s Disease Diagnostic Players Market Share
3.2.2 Top 10 Alzheimer’s Disease Diagnostic Players Market Share
3.2.3 Market Competition Trend
3.3 Alzheimer’s Disease Diagnostic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Alzheimer’s Disease Diagnostic Revenue and Market Share by Type (2016-2021)
4.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2016-2021)
5.2 Alzheimer’s Disease Diagnostic Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)
6.2 North America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Country
6.3.1 North America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)
6.3.2 United States Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
6.3.3 Canada Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
6.3.4 Mexico Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)
7.2 Europe Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Country
7.3.1 Europe Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)
7.3.2 Germany Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
7.3.3 France Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
7.3.5 Russia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
7.3.6 Italy Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)
8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)
8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region
8.3.1 Asia-Pacific Alzheimer’s Disease Diagnostic Revenue by Region (2016-2026)
8.3.2 China Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8.3.3 Japan Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8.3.4 South Korea Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8.3.5 India Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
8.3.7 Australia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)
9.2 South America Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)
9.3 South America Alzheimer’s Disease Diagnostic Market Size by Country
9.3.1 South America Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)
9.3.2 Brazil Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
9.3.3 Argentina Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Type (2016-2026)
10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Application (2016-2026)
10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country
10.3.1 Middle East & Africa Alzheimer’s Disease Diagnostic Revenue by Country (2016-2026)
10.3.2 Turkey Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
10.3.4 UAE Alzheimer’s Disease Diagnostic Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Alzheimer's Disease Diagnostic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Alzheimer's Disease Diagnostic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Alzheimer's Disease Diagnostic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Alzheimer's Disease Diagnostic Revenue (USD Million) by Region (2016-2021)
Table 5. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Alzheimer's Disease Diagnostic Product and Solutions
Table 9. Eli Lilly Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. TauRx Corporate Information, Head Office, and Major Competitors
Table 11. TauRx Major Business
Table 12. TauRx Alzheimer's Disease Diagnostic Product and Solutions
Table 13. TauRx Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Alector Corporate Information, Head Office, and Major Competitors
Table 15. Alector Major Business
Table 16. Alector Alzheimer's Disease Diagnostic Product and Solutions
Table 17. Alector Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Accera Corporate Information, Head Office, and Major Competitors
Table 19. Accera Major Business
Table 20. Accera Alzheimer's Disease Diagnostic Product and Solutions
Table 21. Accera Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Treventis Corporate Information, Head Office, and Major Competitors
Table 23. Treventis Major Business
Table 24. Treventis Alzheimer's Disease Diagnostic Product and Solutions
Table 25. Treventis Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Neuro-Bio Corporate Information, Head Office, and Major Competitors
Table 27. Neuro-Bio Major Business
Table 28. Neuro-Bio Alzheimer's Disease Diagnostic Product and Solutions
Table 29. Neuro-Bio Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cognition Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Cognition Therapeutics Major Business
Table 32. Cognition Therapeutics Alzheimer's Disease Diagnostic Product and Solutions
Table 33. Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Alzheimer's Disease Diagnostic Revenue (USD Million) by Players (2019-2021)
Table 35. Global Alzheimer's Disease Diagnostic Revenue Share by Players (2019-2021)
Table 36. Breakdown of Alzheimer's Disease Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Alzheimer's Disease Diagnostic Players Head Office, Products and Services Provided
Table 38. Alzheimer's Disease Diagnostic Mergers & Acquisitions in the Past Five Years
Table 39. Alzheimer's Disease Diagnostic New Entrants and Expansion Plans
Table 40. Global Alzheimer's Disease Diagnostic Revenue (USD Million) by Type (2016-2021)
Table 41. Global Alzheimer's Disease Diagnostic Revenue Share by Type (2016-2021)
Table 42. Global Alzheimer's Disease Diagnostic Revenue Forecast by Type (2021-2026)
Table 43. Global Alzheimer's Disease Diagnostic Revenue by Application (2016-2021)
Table 44. Global Alzheimer's Disease Diagnostic Revenue Forecast by Application (2021-2026)
Table 45. North America Alzheimer's Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Alzheimer's Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Alzheimer's Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Alzheimer's Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Alzheimer's Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Alzheimer's Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Alzheimer's Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Alzheimer's Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Alzheimer's Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Alzheimer's Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Alzheimer's Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Alzheimer's Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Alzheimer's Disease Diagnostic Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Alzheimer's Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Alzheimer's Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Alzheimer's Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Alzheimer's Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Alzheimer's Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Alzheimer's Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Alzheimer's Disease Diagnostic Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Alzheimer's Disease Diagnostic Picture
Figure 2. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type in 2020
Figure 3. Genetic testing
Figure 4. Neurological exam
Figure 5. Mini-mental state exam (MMSE)
Figure 6. Brain imaging
Figure 7. Other
Figure 8. Alzheimer's Disease Diagnostic Revenue Market Share by Application in 2020
Figure 9. Clinics Picture
Figure 10. Hospitals Picture
Figure 11. Diagnostic Centers Picture
Figure 12. Other Picture
Figure 13. Global Alzheimer's Disease Diagnostic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Alzheimer's Disease Diagnostic Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region (2016-2026)
Figure 16. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region in 2020
Figure 17. North America Alzheimer's Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Alzheimer's Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Alzheimer's Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Alzheimer's Disease Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Alzheimer's Disease Diagnostic Market Drivers
Figure 22. Alzheimer's Disease Diagnostic Market Restraints
Figure 23. Alzheimer's Disease Diagnostic Market Trends
Figure 24. Eli Lilly Recent Developments and Future Plans
Figure 25. TauRx Recent Developments and Future Plans
Figure 26. Alector Recent Developments and Future Plans
Figure 27. Accera Recent Developments and Future Plans
Figure 28. Treventis Recent Developments and Future Plans
Figure 29. Neuro-Bio Recent Developments and Future Plans
Figure 30. Cognition Therapeutics Recent Developments and Future Plans
Figure 32. Global Alzheimer's Disease Diagnostic Revenue Share by Players in 2020
Figure 33. Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Alzheimer's Disease Diagnostic Revenue Market Share in 2020
Figure 35. Global Top 10 Players Alzheimer's Disease Diagnostic Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Alzheimer's Disease Diagnostic Revenue Share by Type in 2020
Figure 38. Global Alzheimer's Disease Diagnostic Market Share Forecast by Type (2021-2026)
Figure 39. Global Alzheimer's Disease Diagnostic Revenue Share by Application in 2020
Figure 40. Global Alzheimer's Disease Diagnostic Market Share Forecast by Application (2021-2026)
Figure 41. North America Alzheimer's Disease Diagnostic Sales Market Share by Type (2016-2026)
Figure 42. North America Alzheimer's Disease Diagnostic Sales Market Share by Application (2016-2026)
Figure 43. North America Alzheimer's Disease Diagnostic Revenue Market Share by Country (2016-2026)
Figure 44. United States Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Alzheimer's Disease Diagnostic Sales Market Share by Type (2016-2026)
Figure 48. Europe Alzheimer's Disease Diagnostic Sales Market Share by Application (2016-2026)
Figure 49. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Country (2016-2026)
Figure 50. Germany Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Alzheimer's Disease Diagnostic Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Alzheimer's Disease Diagnostic Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Region (2016-2026)
Figure 58. China Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Alzheimer's Disease Diagnostic Sales Market Share by Type (2016-2026)
Figure 65. South America Alzheimer's Disease Diagnostic Sales Market Share by Application (2016-2026)
Figure 66. South America Alzheimer's Disease Diagnostic Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Alzheimer's Disease Diagnostic Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Alzheimer's Disease Diagnostic Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Alzheimer's Disease Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). …- 世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） The diagnosis of alzheimer's disease is divided into three steps. The first step is to determine whether it is alzheimer's disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or me…
- 世界のアルツハイマー病市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alzheimer's Disease Market The global Alzheimer's Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimers is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. Alzheimers is one of the leading causes of death in the United States, with more than 5 million Americans diagnosed with this dreaded disease, in year 2014. Market Analysis and Insights: Glob…
- 世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2…